Awake Tracheal Intubation in Critical Care Patients

Sponsor
Johannes Gutenberg University Mainz (Other)
Overall Status
Completed
CT.gov ID
NCT05802316
Collaborator
(none)
140
1
34
4.1

Study Details

Study Description

Brief Summary

Tracheal intubation in critical care is a high-risk procedure requiring significant expertise and airway strategy modifications, such as awake intubation with video laryngoscope or flexible endoscope intubation. Furthermore, delayed sequence intubation can be used by experts in certain high-risk subgroups. The investigators hypothesise that awake tracheal intubation is associated with a lower incidence of severe adverse events than standard tracheal intubation in critical care patients.

Condition or Disease Intervention/Treatment Phase
  • Device: tracheal intubation using videolaryngoscope with a hyperangulated blade or standard intubation videolaryngoscopy (VL) and direct laryngoscopy (DL)

Detailed Description

Intubation records from 2020 to 2022 were acquired to examine all tracheal intubations of critical care patients at a tertiary hospital. Each awake tracheal intubation (awake) case - all of which were performed using a videolaryngoscope with a hyperangulated blade - was propensity matched with two controls (1:2 ratio; standard intubation videolaryngoscopy (VL) and direct laryngoscopy (DL) undergoing general anaesthesia), with similar comorbidities and intubations performed after the induction of anaesthesia (asleep).

Study Design

Study Type:
Observational
Actual Enrollment :
140 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Awake Tracheal Intubation is Associated With Fewer Adverse Events in Critical Care Patients Than Standard Tracheal Intubation
Actual Study Start Date :
Jan 3, 2020
Actual Primary Completion Date :
Apr 30, 2022
Actual Study Completion Date :
Nov 3, 2022

Arms and Interventions

Arm Intervention/Treatment
awake

awake tracheal intubation

Device: tracheal intubation using videolaryngoscope with a hyperangulated blade or standard intubation videolaryngoscopy (VL) and direct laryngoscopy (DL)
In the awake group tracheal intubation performed by an videolaryngoscope with a hyperangulated blade. In the asleep group the standard intubation were performed by videolaryngoscopy (VL) and direct laryngoscopy (DL)

asleep

standard intubation videolaryngoscopy (VL) and direct laryngoscopy (DL)

Device: tracheal intubation using videolaryngoscope with a hyperangulated blade or standard intubation videolaryngoscopy (VL) and direct laryngoscopy (DL)
In the awake group tracheal intubation performed by an videolaryngoscope with a hyperangulated blade. In the asleep group the standard intubation were performed by videolaryngoscopy (VL) and direct laryngoscopy (DL)

Outcome Measures

Primary Outcome Measures

  1. Hypotension [during intubation procedure (within 30 Minutes)]

    defined as a mean arterial pressure < 55 mmHg

  2. cardiac arrest [during intubation procedure (within 30 Minutes)]

    defined as a peri-interventional cardiac arrest

  3. desaturation [during intubation procedure (within 30 Minutes)]

    defined as SpO2 < 80% after sufficient preoxygenation

Secondary Outcome Measures

  1. Cormack and Lehane classification (Class I-IV) [during intubation procedure (< 120 seconds)]

    glottis visualisation

  2. FPS [during intubation procedure (< 120 seconds)]

    First Pass Intubation success

  3. Airway Injury [during intubation procedure (< 120 seconds)]

    dental injury

  4. other adverse events [during intubation procedure (< 120 seconds)]

    soft tissue injury

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Data for all critical care patients requiring tracheal intubation during the study period
Exclusion Criteria:
  • included incomplete data reports

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Anesthesiology,Prof. C. Werner, Universitätsmedizin of the JG University Mainz Rhineland-Palatinate Germany D55131

Sponsors and Collaborators

  • Johannes Gutenberg University Mainz

Investigators

  • Principal Investigator: Marc Kriege, University Medical Centre Mainz

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Marc Kriege, MD, Principal Investigator, Johannes Gutenberg University Mainz
ClinicalTrials.gov Identifier:
NCT05802316
Other Study ID Numbers:
  • JohannesGUK
First Posted:
Apr 6, 2023
Last Update Posted:
Apr 6, 2023
Last Verified:
Apr 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Apr 6, 2023